


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T13:52:53Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12405386" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12405386</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Cardiovasc Imaging</journal-id><journal-id journal-id-type="iso-abbrev">Int J Cardiovasc Imaging</journal-id><journal-id journal-id-type="pmc-domain-id">365</journal-id><journal-id journal-id-type="pmc-domain">springeropen</journal-id><journal-title-group><journal-title>The International Journal of Cardiovascular Imaging</journal-title></journal-title-group><issn pub-type="ppub">1569-5794</issn><issn pub-type="epub">1875-8312</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Springer</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12405386</article-id><article-id pub-id-type="pmcid-ver">PMC12405386.1</article-id><article-id pub-id-type="pmcaid">12405386</article-id><article-id pub-id-type="pmcaiid">12405386</article-id><article-id pub-id-type="pmid">40748415</article-id><article-id pub-id-type="doi">10.1007/s10554-025-03471-1</article-id><article-id pub-id-type="publisher-id">3471</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>Agatston scoring for assessment of coronary artery disease in patients undergoing transcatheter aortic valve implantation</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" equal-contrib="yes"><name name-style="western"><surname>Mostafa</surname><given-names initials="K">Karim</given-names></name><address><email>karim.mostafa@uksh.de</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Voran</surname><given-names initials="JC">Jakob Christoph</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>M&#252;ller</surname><given-names initials="M">Markus</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Pohlmeyer</surname><given-names initials="A">Anka</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Noormalal</surname><given-names initials="M">Marie</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Salem</surname><given-names initials="M">Mostafa</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Saad</surname><given-names initials="M">Mohammed</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Langguth</surname><given-names initials="P">Patrick</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Frank</surname><given-names initials="D">Derk</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wolf</surname><given-names initials="C">Carmen</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Seoudy</surname><given-names initials="H">Hatim</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01tvm6f46</institution-id><institution-id institution-id-type="GRID">grid.412468.d</institution-id><institution-id institution-id-type="ISNI">0000 0004 0646 2097</institution-id><institution>Department of Radiology and Neuroradiology, </institution><institution>University Hospital Schleswig-Holstein, </institution></institution-wrap>Campus Kiel, Kiel, Germany </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01tvm6f46</institution-id><institution-id institution-id-type="GRID">grid.412468.d</institution-id><institution-id institution-id-type="ISNI">0000 0004 0646 2097</institution-id><institution>Department of Internal Medicine III, Cardiology and critical care, </institution><institution>University Hospital Schleswig-Holstein, </institution></institution-wrap>Campus Kiel, Kiel, Germany </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/031t5w623</institution-id><institution-id institution-id-type="GRID">grid.452396.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 5937 5237</institution-id><institution>DZHK (German Centre for Cardiovascular Research), </institution></institution-wrap>partner site Hamburg/Kiel/L&#252;beck, Kiel, Germany </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01tvm6f46</institution-id><institution-id institution-id-type="GRID">grid.412468.d</institution-id><institution-id institution-id-type="ISNI">0000 0004 0646 2097</institution-id><institution>Department of Radiology and Neuroradiology, </institution><institution>UKSH Kiel, </institution></institution-wrap>Arnold-Heller-Stra&#223;e 3, 24015 Kiel, Germany </aff></contrib-group><pub-date pub-type="epub"><day>1</day><month>8</month><year>2025</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>41</volume><issue>9</issue><issue-id pub-id-type="pmc-issue-id">496088</issue-id><fpage>1729</fpage><lpage>1738</lpage><history><date date-type="received"><day>1</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>21</day><month>7</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>08</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 00:25:59.930"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="10554_2025_Article_3471.pdf"/><abstract id="Abs1"><p id="Par1">Computed tomography (CT) angiography remains a cornerstone of pre-interventional assessment for transaortic valve implantation (TAVI). CT imaging prior to TAVI further allows for evaluation of the coronary arteries, with the simplest method being the calculation of the coronary Agatston score. Following the expansion of TAVI to lower risk patients, non-invasive coronary diagnostics in the framework of TAVI gain importance as they may allow patients to avoid unnecessary invasive coronary angiography (ICA) before the procedure. This study evaluates the diagnostic performance of coronary Agatston score values on pre-TAVI CT scans for the assessment of coronary artery disease.&#160;A total of 285 patients received a standard TAVI evaluation CT scan and routine ICA prior to the TAVI procedure. Agatston score values of the coronary tree and the proximal coronary segments (1, 5, 6, 11) were calculated separately by two radiologists. Reference for the AUC analysis was performance of PCI or stenting of the corresponding coronary segment following the recommendation of the Heart Team. ROC-analysis was performed for evaluation of the Agatston score at the level of the heart, the coronary arteries and the proximal coronary vessel segments (1, 5, 6 and 11) level to determine cutoff-values for optimal sensitivity and specificity.&#160;A total of 285 patients received a standard TAVI evaluation CT scan and routine ICA prior to the TAVI procedure. Agatston score values of the coronary tree and the proximal coronary segments (1, 5, 6, 11) were calculated separately by two radiologists. Reference for the AUC analysis was performance of PCI or stenting of the corresponding coronary segment following the recommendation of the Heart Team. ROC-analysis was performed for evaluation of the Agatston score at the level of the heart, the coronary arteries and the proximal coronary vessel segments (1, 5, 6 and 11) level to determine cutoff-values for optimal sensitivity and specificity.&#160;Coronary artery disease requiring intervention was present in 61 patients upon ICA (17.9%). In predicting the need&#160;of performance of a coronary intervention at a sensitivity of &gt;89%, Agatston values of the full coronary tree &gt;170 allow for&#160;a sensitivity of 90% (AUC 0.76, NPV 0.93). The sum Agatston score of the proximal segments &gt;117 enables a sensitivity of&#160;90% (AUC 0.74, NPV 0.93) and &gt;47 a sensitivity of 98% (NPV 0.98). On the segmental level, Agatston values of &gt;22 in&#160;the proximal RCA and &gt;30 in the proximal LAD and CX allow for a sensitivity of 90% (AUC RCA 0.74, NPV 0.98; LAD&#160;0.71, NPV 0.94; CX 0.75, NPV 0.99). Aiming for 98% sensitivity or higher, Agatston values of &gt;2 for the RCA, &gt;3 for the&#160;LAD and &gt;27 for the CX apply (RCA NPV 1; LAD NPV 0.97; CX NPV 1).&#160;Coronary artery Agatston scoring on TAVI evaluation CT scans can serve as a predictor for the need of coronary interventions in the workup leading up to TAVI and it provides valuable information for identification of patients without significant coronary artery disease and may aid in allowing for the avoidance of invasive coronary artery diagnostics.</p><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1007/s10554-025-03471-1.</p></sec></abstract><funding-group><award-group><funding-source><institution>Universit&#228;tsklinikum Schleswig-Holstein - Campus Kiel (6509)</institution></funding-source></award-group><open-access><p>Open Access funding enabled and organized by Projekt DEAL.</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer Nature B.V. 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par11">Transcatheter aortic valve replacement (TAVI) is an established procedure where the aortic valve is replaced in a minimally invasive fashion. Over the course of the past decade, indications for TAVI have expanded to lower risk patients, emphasizing the importance of pre-interventional diagnostic workup for best-possible patient selection.</p><p id="Par12">International guidelines on the management of valvular heart disease suggest that proximal coronary arterial stenosis be assessed and treated with percutaneous coronary intervention prior to TAVI (ESC, Class IIa, C) and ACC/AHA (Class 2a, C-LD)) [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. While interventional angiography remains the best possible means of vascular assessment, the disadvantages of it being an interventional procedure carrying risks and requiring arterial access, even if only performed with diagnostic intent, need to be considered [<xref ref-type="bibr" rid="CR3">3</xref>]. Considering expansion of the indication for the TAVI procedure to lower risk patients, mandatory invasive coronary diagnostics may expose patients to non-benefiting risky diagnostic procedures while compromising safety and not upholding cost-effectiveness. Hence, the importance of best-possible non-invasive diagnostics as well as the screening-character of the pre-TAVI examinations, especially cardiac computed tomography, need to be reinforced.</p><p id="Par13">Cardiac and thoracoabdominal computed tomography remain the gold standard imaging methods for planning of the TAVI procedure [<xref ref-type="bibr" rid="CR1">1</xref>]. In the framework of cardiac CT imaging in patients undergoing TAVI, it has been debated as to whether assessment of the coronary arteries can be purposefully completed with CT and CTA [<xref ref-type="bibr" rid="CR4">4</xref>&#8211;<xref ref-type="bibr" rid="CR9">9</xref>]. However, standard TAVI-CT protocols are not dedicated for the detailed assessment of the coronary arteries by default and often do not allow for it. Furthermore, patients with severe symptomatic aortic stenosis in evaluation for TAVI cannot be adequately prepared for such coronary-specific CT with betablockers and nitroglycerin [<xref ref-type="bibr" rid="CR9">9</xref>&#8211;<xref ref-type="bibr" rid="CR11">11</xref>]. In recent years, different studies have covered the topic of coronary artery evaluation on TAVI-planning CT, however the results have not shown a clear trend. Most of these studies focused on diagnosis of significant coronary artery stenosis with often no regard as to whether treatment for the stenosis was performed [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>].</p><p id="Par14">The aim of this study was to investigate the value of coronary artery Agatston scoring on non-contrast cardiac CT scans as an independent marker for coronary artery disease in need of treatment in patients undergoing TAVI. Focus was put on Agatston analysis of the full coronary tree and a segment-by-segment analysis of the proximal coronary arteries.</p></sec><sec id="Sec2"><title>Materials and methods</title><p id="Par15">This single centre retrospective study included all consecutive patients undergoing transfemoral TAVI between January 2018 and May 2022 at the University hospital Schleswig-Holstein in Kiel, Germany. Patients with insufficient visualization of the coronary arteries due to motion artefacts on CT imaging, in place coronary artery bypass, a coronary stent or with cardiac implantable electronic devices were excluded. A detailed consort flow diagram is included in the supplementary file. The study was approved by the ethics committee of the Christian-Albrechts-University in Kiel (Votum No. AZ D 506/22).</p><sec id="Sec3"><title>CT imaging and imaging evaluation</title><p id="Par16">CT imaging prior to the TAVI procedure was completed on one designated CT scanner (Definition Flash Siemens, Erlangen, Germany). Scanning parameters of the TAVI evaluation CT-imaging were standardised with the following parameters: tube voltage 100&#160;kV, tube current time product 59 mAS, slice collimation 2.0&#8201;&#215;&#8201;128&#8201;&#215;&#8201;0.6&#160;mm, pitch factor 1.2.</p><p id="Par17">CT-imaging evaluation was completed in a two-step process. In the first step, non-enhanced imaging acquisition of the heart was completed for calculation of the Agaston-Score values of the full coronary tree, defined as overall Agatston score. In the second step, the Agatston score values were separately calculated for the proximal segments of the LAD, RCA and CX, whereby calcium scoring was performed for segments 1, 5, 6 and 11 [<xref ref-type="bibr" rid="CR14">14</xref>]. Scoring was done manually by two radiologists with a designated assessment tool (C.W. and K.M., SyngoVia, Siemens, Erlangen, Germany; Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>). Both radiologists were blinded to the results of the invasive coronary angiography.</p><p id="Par18">
<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>Graphic visualisation of measurements of Agatston-Score values on pre-TAVI CT imaging. On non-enhanced cardiac CT imaging (a, d), calcified lesions were identified and matched with the contrast-enhanced images (b, e). Afterwards, the calcified lesions were colour-coded and the Agatston-Score values were determined using imaging postprocessing software (SnygoVia, Siemens). In images a-c, evaluation of the LAD is visualised while in images e-f evaluation of the aortic valve is displayed</p></caption><graphic id="d33e366" position="float" orientation="portrait" xlink:href="10554_2025_3471_Fig1_HTML.jpg"/></fig>
</p></sec><sec id="Sec4"><title>Invasive coronary angiography</title><p id="Par19">All patients routinely underwent invasive coronary angiography (ICA) prior to the TAVI procedure. ICA was used to identify stenosis in need of potential treatment. The decision for treatment, whether interventional or conservative, was discussed in the multidisciplinary heart team considering the clinical and imaging findings. The heart team decision for stent placement was based on the location of the stenosis (proximal segments, left main trunk) and diameter (&gt;&#8201;70% stenosis or &gt;&#8201;50% for left main trunk).</p></sec><sec id="Sec5"><title>Statistics and data analysis</title><p id="Par20">Data are presented as mean&#8201;&#177;&#8201;SD, median&#8201;&#177;&#8201;IQR or percentages as indicated. T-test or Mann-Whitney U test was applied for analysis of continuous variables while categorical data were analysed using the &#967;2 test or Fisher&#8217;s exact test. Statistical significance was considered given a two-sided p-value of less than 0.05. ROC-Analysis for Agatston values was conducted for the full coronary tree and the proximal coronary segments. Benchmark for the analysis was presence of a stenosis that received interventional treatment on all levels of assessment. Segmental analysis focussed on the proximal segments of the RCA (segment 1), the LAD (segment 5 and 6) and the CX (segment 11). Statistical analyses were done using R version 4.4.1.</p></sec></sec><sec id="Sec6"><title>Results</title><sec id="Sec7"><title>Patients</title><p id="Par21">A total of 285 consecutive patients were included in the final analysis. Baseline demographic and clinical characteristics are summarized in Table&#160;<xref rid="Tab1" ref-type="table">1</xref>. The cohort was divided into two groups &#8211; the &#8220;PCI group&#8221; included 61 patients in whom coronary angiography identified lesions in need of treatment and who subsequently underwent percutaneous coronary intervention. The &#8220;No PCI group&#8221; included 223 patients who showed no significant CAD in need of treatment upon invasive coronary angiography. Patients in the PCI group were significantly older (82.4 years vs. 80.4 years, <italic toggle="yes">p</italic>&#8201;=&#8201;0.033; Table&#160;<xref rid="Tab1" ref-type="table">1</xref>). Further, the proportion of male patients was higher in the PCI group (54% vs. 42%, <italic toggle="yes">p</italic>&#8201;=&#8201;0.011; Table&#160;1). Beyond age, no further significant baseline differences could be detected.<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Baseline Characteristics</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"><bold>Characteristic</bold></th><th align="left" colspan="1" rowspan="1"><bold>Overall</bold>, N = 285 <sup>1</sup></th><th align="left" colspan="1" rowspan="1"><bold>Intervention</bold></th><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1"><bold>p-value</bold><sup>2</sup></th></tr><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1"><bold>No</bold>, N = 224<sup>1</sup></th><th align="left" colspan="1" rowspan="1"><bold>Yes</bold>, N = 61<sup>1</sup></th><th align="left" colspan="1" rowspan="1"/></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Age</td><td align="left" colspan="1" rowspan="1">80.82 (6.28)</td><td align="left" colspan="1" rowspan="1">80.37 (6.45)</td><td align="left" colspan="1" rowspan="1">82.43 (5.37)</td><td align="left" colspan="1" rowspan="1">0.034</td></tr><tr><td align="left" colspan="1" rowspan="1">Sex, male</td><td align="left" colspan="1" rowspan="1">126 / 285 (44%)</td><td align="left" colspan="1" rowspan="1">93 / 224 (42%)</td><td align="left" colspan="1" rowspan="1">33 / 61 (54%)</td><td align="left" colspan="1" rowspan="1">0.011</td></tr><tr><td align="left" colspan="1" rowspan="1">BMI</td><td align="left" colspan="1" rowspan="1">27.60 (6.02)</td><td align="left" colspan="1" rowspan="1">27.69 (6.24)</td><td align="left" colspan="1" rowspan="1">27.42 (5.16)</td><td align="left" colspan="1" rowspan="1">0.8</td></tr><tr><td align="left" colspan="1" rowspan="1">Atrial Fibrillation/Flutter</td><td align="left" colspan="1" rowspan="1">110 / 285 (39%)</td><td align="left" colspan="1" rowspan="1">85 / 224 (38%)</td><td align="left" colspan="1" rowspan="1">25 / 61 (40%)</td><td align="left" colspan="1" rowspan="1">0.7</td></tr><tr><td align="left" colspan="1" rowspan="1">COPD</td><td align="left" colspan="1" rowspan="1">33 / 285 (12%)</td><td align="left" colspan="1" rowspan="1">27 / 224 (12%)</td><td align="left" colspan="1" rowspan="1">6 / 61 (11%)</td><td align="left" colspan="1" rowspan="1">0.6</td></tr><tr><td align="left" colspan="1" rowspan="1">Diabetes</td><td align="left" colspan="1" rowspan="1">80 / 285 (28%)</td><td align="left" colspan="1" rowspan="1">62 / 224 (28%)</td><td align="left" colspan="1" rowspan="1">18 / 61 (29%)</td><td align="left" colspan="1" rowspan="1">0.8</td></tr><tr><td align="left" colspan="1" rowspan="1">Dyslipidemia</td><td align="left" colspan="1" rowspan="1">174 / 285 (61%)</td><td align="left" colspan="1" rowspan="1">138 / 224 (62%)</td><td align="left" colspan="1" rowspan="1">36 / 61 (58%)</td><td align="left" colspan="1" rowspan="1">0.7</td></tr><tr><td align="left" colspan="1" rowspan="1">Hypertension</td><td align="left" colspan="1" rowspan="1">265 / 285 (93%)</td><td align="left" colspan="1" rowspan="1">208 / 224 (93%)</td><td align="left" colspan="1" rowspan="1">57 / 61 (94%)</td><td align="left" colspan="1" rowspan="1">&gt;0.9</td></tr><tr><td align="left" colspan="1" rowspan="1">PAD</td><td align="left" colspan="1" rowspan="1">14 / 285 (4.9%)</td><td align="left" colspan="1" rowspan="1">10 / 224 (4.5%)</td><td align="left" colspan="1" rowspan="1">4 / 61 (6.5%)</td><td align="left" colspan="1" rowspan="1">0.5</td></tr><tr><td align="left" colspan="1" rowspan="1">Cerebrovascular disease</td><td align="left" colspan="1" rowspan="1">42 / 285 (15%)</td><td align="left" colspan="1" rowspan="1">31 / 224 (14%)</td><td align="left" colspan="1" rowspan="1">11 / 61 (18%)</td><td align="left" colspan="1" rowspan="1">0.4</td></tr><tr><td align="left" colspan="1" rowspan="1">History of smoking</td><td align="left" colspan="1" rowspan="1">49/285 (17,2%)</td><td align="left" colspan="1" rowspan="1">38 / 224 (17%)</td><td align="left" colspan="1" rowspan="1">11 / 61 (18%)</td><td align="left" colspan="1" rowspan="1">0.8</td></tr><tr><td align="left" colspan="1" rowspan="1">Family history for myocardial infarction<sup>3</sup></td><td align="left" colspan="1" rowspan="1">8/285 (2,8%)</td><td align="left" colspan="1" rowspan="1">4 / 224 (1.8%) </td><td align="left" colspan="1" rowspan="1">4 / 61 (6.6%)</td><td align="left" colspan="1" rowspan="1">0.067</td></tr><tr><td align="left" colspan="1" rowspan="1">Baseline GFR (MDRD)</td><td align="left" colspan="1" rowspan="1">55.45 (20.34)</td><td align="left" colspan="1" rowspan="1">56.67 (20.41)</td><td align="left" colspan="1" rowspan="1">51.15 (19.65)</td><td align="left" colspan="1" rowspan="1">0.074</td></tr><tr><td align="left" colspan="1" rowspan="1">AVA</td><td align="left" colspan="1" rowspan="1">0.8 (0.2)</td><td align="left" colspan="1" rowspan="1">0.8 (0.2)</td><td align="left" colspan="1" rowspan="1">0.7 (0.2)</td><td align="left" colspan="1" rowspan="1">0.061</td></tr><tr><td align="left" colspan="1" rowspan="1">Reduced left ventricular ejection fraction (&lt;55%)</td><td align="left" colspan="1" rowspan="1">73 / 248 (29%)</td><td align="left" colspan="1" rowspan="1">55 / 195 (28%)</td><td align="left" colspan="1" rowspan="1">18 / 53 (34%)</td><td align="left" colspan="1" rowspan="1">0.4</td></tr></tbody></table><table-wrap-foot><p><sup>1</sup>Mean (SD); n / N (%)</p><p><sup>2</sup>Wilcoxon rank sum test; Pearson's Chi-squared test; Fisher's exact test</p><p><sup>3</sup>not systematically evaluated due to limited clinical relevance in an elderly TAVI cohort</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec8"><title>Capability of the Agatston score of the full coronary tree for prediction of relevant stenosis</title><p id="Par22">Upon non-contrast enhanced cardiac CT, the PCI group showed higher total Agatston scores (3,286 vs. 5,092) and higher Agatston scores for the full coronary tree (303 vs. 1,313) with both results being significant (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001). The Agatston Score of the aortic valve alone was non-significantly higher in the PCI group (2,589 vs. 2,972, <italic toggle="yes">p</italic>&#8201;=&#8201;0.056; Table&#160;<xref rid="Tab2" ref-type="table">2</xref>).<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Characteristics of the coronary artery calcium score</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"><bold>Characteristic</bold></th><th align="left" colspan="1" rowspan="1"><bold>Overall</bold>, N = 285<sup>1</sup></th><th align="left" colspan="1" rowspan="1"><bold>Intervention</bold></th><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1"><bold>p-value</bold><sup>2</sup></th></tr><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1"><bold>No</bold>, N = 224</th><th align="left" colspan="1" rowspan="1"><bold>Yes</bold>, N = 61<sup>1</sup></th><th align="left" colspan="1" rowspan="1"/></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Agatston score total</td><td align="left" colspan="1" rowspan="1">3,523 (2,187, 5,445)</td><td align="left" colspan="1" rowspan="1">3,286 (2,068, 4,743)</td><td align="left" colspan="1" rowspan="1">5,092 (3,126, 7,019)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Agatston score aortic valve</td><td align="left" colspan="1" rowspan="1">2,688 (1,675, 4,214)</td><td align="left" colspan="1" rowspan="1">2,589 (1,621, 4,070)</td><td align="left" colspan="1" rowspan="1">2,972 (1,848, 4,840)</td><td align="left" colspan="1" rowspan="1">0.056</td></tr><tr><td align="left" colspan="1" rowspan="1">Agatston score heart</td><td align="left" colspan="1" rowspan="1">430 (131, 1,142)</td><td align="left" colspan="1" rowspan="1">303 (85, 831)</td><td align="left" colspan="1" rowspan="1">1,313 (464, 2,626)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Agatston score proximal segments</td><td align="left" colspan="1" rowspan="1">272 (83, 680)</td><td align="left" colspan="1" rowspan="1">193 (66, 498)</td><td align="left" colspan="1" rowspan="1">675 (312, 1,625)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">LMT Agatston score</td><td align="left" colspan="1" rowspan="1">18 (0, 96)</td><td align="left" colspan="1" rowspan="1">9 (0, 72)</td><td align="left" colspan="1" rowspan="1">80 (11, 217)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">LAD Agatston score</td><td align="left" colspan="1" rowspan="1">90 (20, 242)</td><td align="left" colspan="1" rowspan="1">66 (10, 199)</td><td align="left" colspan="1" rowspan="1">260 (77, 438)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">LCX Agatston score</td><td align="left" colspan="1" rowspan="1">32 (0, 132)</td><td align="left" colspan="1" rowspan="1">24 (0, 103)</td><td align="left" colspan="1" rowspan="1">84 (9, 277)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">RCA Agatston score</td><td align="left" colspan="1" rowspan="1">36 (1, 199)</td><td align="left" colspan="1" rowspan="1">25 (0, 110)</td><td align="left" colspan="1" rowspan="1">155 (33, 449)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr></tbody></table><table-wrap-foot><p><sup>1</sup>Median (IQR)</p><p><sup>2</sup>Wilcoxon rank sum test</p></table-wrap-foot></table-wrap></p><p id="Par23">Considering the full coronary tree, we found an area under the curve of 0.76 (95% CI 0.69&#8211;0.82) for prediction of a stenosis in need of treatment in the ROC. Following the Youdens Index, the threshold for overall coronary artery score values with highest sensitivity and specificity was at 981 with a sensitivity of 80% and a specificity of 60%. Considering an overall Agatston value of 170, sensitivity will be at 90% with specificity at 36%. This result is presented in Figs.&#160;<xref rid="Fig2" ref-type="fig">2</xref>, <xref rid="Fig3" ref-type="fig">3</xref>; Table&#160;<xref rid="Tab3" ref-type="table">3</xref>. Choosing this sensitivity would avoid ICA in 31% of patients in our cohort. A sensitivity of over 98% (Table&#160;<xref rid="Tab4" ref-type="table">4</xref>) leads to a lower proportion of patients in whom an ICA could be potentially avoided.</p><p id="Par24">
<fig id="Fig2" position="float" orientation="portrait"><label>Fig. 2</label><caption><p>ROC-Analysis, Sensitivity and Specificity values for prediction of PCI prior to TAVI. <bold>A</bold>: Receiver operating characteristic (ROC) for Agatston values of the full coronary tree, <bold>B</bold>: Sensitivity and specificity for selected thresholds of interest of the full heart, <bold>C</bold>: Receiver operating characteristic for the sum Agatston Score of the proximal coronary arteries. <bold>D</bold>: Correlation of full heart Agatston score and sum Agatston score of the proximal segments (dark blue: &#8220;No PCI group&#8221;, light blue: &#8220;PCI group&#8221; AUC: area under the curve, SE: Sensitivity, SP: Specificity,</p></caption><graphic id="d33e814" position="float" orientation="portrait" xlink:href="10554_2025_3471_Fig2_HTML.jpg"/></fig>
<fig id="Fig3" position="float" orientation="portrait"><label>Fig. 3</label><caption><p>ROC-Analysis for determination of threshold Agatston values of the RCA, LAD and LCX. Abbreviations: AUC: area under the curve, LAD: Left anterior descending coronary artery, LCX: Circumflex coronary artery, RCA: Right coronary artery, SE: Sensitivity, SP: Specificity,</p></caption><graphic id="d33e822" position="float" orientation="portrait" xlink:href="10554_2025_3471_Fig3_HTML.jpg"/></fig>
<table-wrap id="Tab3" position="float" orientation="portrait"><label>Table 3</label><caption><p>Different Agatston Score values and locations for prediction of a coronary stenosis in need of treatment with a target sensitivity of 89% and higher</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">
<bold>Agatston Score Location</bold>
</th><th align="left" colspan="1" rowspan="1">
<bold>Agatston Threshold Value</bold>
</th><th align="left" colspan="1" rowspan="1">
<bold>Sensitivity</bold>
</th><th align="left" colspan="1" rowspan="1">
<bold>Specificity</bold>
</th><th align="left" colspan="1" rowspan="1">
<bold>NPV</bold>
</th><th align="left" colspan="1" rowspan="1">
<bold>PPV</bold>
</th><th align="left" colspan="1" rowspan="1">
<bold>PNIA</bold>
</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Overall Coronary Tree</td><td align="left" colspan="1" rowspan="1">170</td><td align="left" colspan="1" rowspan="1">90%</td><td align="left" colspan="1" rowspan="1">36%</td><td align="left" colspan="1" rowspan="1">93%</td><td align="left" colspan="1" rowspan="1">28%</td><td align="left" colspan="1" rowspan="1">31%</td></tr><tr><td align="left" colspan="1" rowspan="1">Proximal Segments (1, 5, 6, 11)</td><td align="left" colspan="1" rowspan="1">117</td><td align="left" colspan="1" rowspan="1">90%</td><td align="left" colspan="1" rowspan="1">36%</td><td align="left" colspan="1" rowspan="1">93%</td><td align="left" colspan="1" rowspan="1">28%</td><td align="left" colspan="1" rowspan="1">31%</td></tr><tr><td align="left" colspan="1" rowspan="1">RCA (Segment 1)</td><td align="left" colspan="1" rowspan="1">22</td><td align="left" colspan="1" rowspan="1">89%</td><td align="left" colspan="1" rowspan="1">44%</td><td align="left" colspan="1" rowspan="1">98%</td><td align="left" colspan="1" rowspan="1">10%</td><td align="left" colspan="1" rowspan="1">42%</td></tr><tr><td align="left" colspan="1" rowspan="1">LAD (Segments 5 and 6)</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">90%</td><td align="left" colspan="1" rowspan="1">32%</td><td align="left" colspan="1" rowspan="1">94%</td><td align="left" colspan="1" rowspan="1">21%</td><td align="left" colspan="1" rowspan="1">29%</td></tr><tr><td align="left" colspan="1" rowspan="1">CX (Segment 11)</td><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">89%</td><td align="left" colspan="1" rowspan="1">50%</td><td align="left" colspan="1" rowspan="1">99%</td><td align="left" colspan="1" rowspan="1">5%</td><td align="left" colspan="1" rowspan="1">48%</td></tr></tbody></table><table-wrap-foot><p>CX: Circumflex coronary artery, LAD: Left anterior descending coronary artery, NPV: negative predictive value; PNIA: Percentage of patients with a <bold>P</bold>otential <bold>N</bold>on-<bold>I</bold>nvasive <bold>A</bold>ssessment prior to TAVI (of the respective segment), PPV: positive predictive value, RCA: Right coronary artery</p></table-wrap-foot></table-wrap>
<table-wrap id="Tab4" position="float" orientation="portrait"><label>Table 4</label><caption><p>Different Agatston Score values and locations for prediction of a coronary stenosis in need of treatment with a target sensitivity of 98% and higher</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">
<bold>Agatston Score Location</bold>
</th><th align="left" colspan="1" rowspan="1">
<bold>Agatston Threshold Value</bold>
</th><th align="left" colspan="1" rowspan="1">
<bold>Sensitivity</bold>
</th><th align="left" colspan="1" rowspan="1">
<bold>Specificity</bold>
</th><th align="left" colspan="1" rowspan="1">
<bold>NPV</bold>
</th><th align="left" colspan="1" rowspan="1">
<bold>PPV</bold>
</th><th align="left" colspan="1" rowspan="1">
<bold>PNIA</bold>
</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Overall Coronary Tree</td><td align="left" colspan="1" rowspan="1">50</td><td align="left" colspan="1" rowspan="1">98%</td><td align="left" colspan="1" rowspan="1">18%</td><td align="left" colspan="1" rowspan="1">98%</td><td align="left" colspan="1" rowspan="1">25%</td><td align="left" colspan="1" rowspan="1">14</td></tr><tr><td align="left" colspan="1" rowspan="1">Proximal Segments (1, 5, 6, 11)</td><td align="left" colspan="1" rowspan="1">47</td><td align="left" colspan="1" rowspan="1">98%</td><td align="left" colspan="1" rowspan="1">20%</td><td align="left" colspan="1" rowspan="1">98%</td><td align="left" colspan="1" rowspan="1">25%</td><td align="left" colspan="1" rowspan="1">16</td></tr><tr><td align="left" colspan="1" rowspan="1">RCA (Segment 1)</td><td align="left" colspan="1" rowspan="1">2</td><td align="left" colspan="1" rowspan="1">99%</td><td align="left" colspan="1" rowspan="1">28%</td><td align="left" colspan="1" rowspan="1">100%</td><td align="left" colspan="1" rowspan="1">9%</td><td align="left" colspan="1" rowspan="1">26</td></tr><tr><td align="left" colspan="1" rowspan="1">LAD (Segment 5 and 6)</td><td align="left" colspan="1" rowspan="1">3</td><td align="left" colspan="1" rowspan="1">98%</td><td align="left" colspan="1" rowspan="1">14%</td><td align="left" colspan="1" rowspan="1">97%</td><td align="left" colspan="1" rowspan="1">19%</td><td align="left" colspan="1" rowspan="1">12</td></tr><tr><td align="left" colspan="1" rowspan="1">CX (Segment 11)</td><td align="left" colspan="1" rowspan="1">27</td><td align="left" colspan="1" rowspan="1">99%</td><td align="left" colspan="1" rowspan="1">49%</td><td align="left" colspan="1" rowspan="1">100%</td><td align="left" colspan="1" rowspan="1">6%</td><td align="left" colspan="1" rowspan="1">47</td></tr></tbody></table><table-wrap-foot><p>CX: Circumflex coronary artery, LAD: Left anterior descending coronary artery, NPV: negative predictive value; PNIA: Percentage of patients with a <bold>P</bold>otential <bold>N</bold>on-<bold>I</bold>nvasive <bold>A</bold>ssessment prior to TAVI (of the respective segment), PPV: positive predictive value, RCA: Right coronary artery</p></table-wrap-foot></table-wrap>
</p></sec><sec id="Sec9"><title>Agatston score analysis for sum scores of the proximal segments of LAD, CX and RCA</title><p id="Par26">The heart team&#8217;s recommendation for stents was made for proximal stenoses, as these were considered to be particularly prognostically relevant. We therefore performed the analysis for the Agatston scores of the proximal segments in order to examine whether this would affect the predictive power of the results.</p><p id="Par27">The sum of the Agatston scores of the proximal coronary segments was significantly lower in the &#8220;No PCI group&#8221; compared to the &#8220;PCI group&#8221; (165 vs. 193, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001). ROC analysis has shown an AUC of 0.74 for prediction of a stenosis in need of treatment. Considering the threshold of 117, sensitivity will be at 90% with a specificity of 36% (Table&#160;3). The negative predictive value (NPV) is at 0.93. When using a sensitivity threshold of 98%, the Agatston score threshold is placed at 47 with an NPV of 0.98) (Table&#160;4). In both cases the predictive quality was comparable to the Agatston score of the full coronary tree.</p></sec><sec id="Sec10"><title>Segmental Agatston scoring for proximal segments of LAD, RCA and CX</title><p id="Par28">Patients in the &#8220;No PCI&#8221; group showed significantly lower Agatston score values for proximal segments of the LAD (segment 5 and 6, 66 vs. 260, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001), RCA (segment 1, 25 vs. 255, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001) and CX (segment 11, 24 vs. 84, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;0.001), respectively. ROC analysis for prediction of a relevant stenosis of the RCA (segment 1) showed an AUC of 0.74. At the score value of 22, a sensitivity of 95% could be achieved at a specificity of 44% (NPV 0.98). For the LAD (segment 5 and 6), we found an AUC of 0.71, whereby a sensitivity of 90% could be achieved when using the score value 30 as threshold, however specificity remained low at 32% (NPV 0.94). Finally, for the CX (segment 11), we calculated an AUC of 0.75. Here we found a sensitivity of 89% at a specificity of 50% at the threshold value of 30 (NPV 0.99; Table&#160;3).</p><p id="Par29">When considering a sensitivity threshold of 98% or higher, the threshold for the RCA (segment 1) is at 2 (NPV 1), for the LAD (segment 5 and 6) at 3 (NPV 0.97) and for the CX (segment 11) at 27 (NPV 1; Table&#160;4).</p></sec><sec id="Sec11"><title>Performance of the Agatston score of the entire coronary tree for the prediction of stenoses</title><sec id="Sec12"><title>&gt;&#8201;70% without consideration of need for PCI</title><p id="Par30">In 26 patients we found stenoses&#8201;&gt;&#8201;70% at any coronary artery in the &#8220;No PCI group&#8221;. Reasons for not intervening these stenoses were small insignificant vessels or a chronic total occlusion without a benefit of intervention. In one patient PCI was avoided as the bleeding risk associated with the dual antiplatelet therapy was considered unfavourable in view of an imminent urgent operation. We reanalysed the data set with &gt;&#8201;70 stenoses as a benchmark to obtain comparable data and minimise bias. This resulted in an area under the curve of 0.72 (95% CI 0.65&#8211;0.78) (Supplementary Fig.&#160;2). The Agatston score value to archive a sensitivity of 98% was slightly lower than for prediction stenoses that underwent PCI, hence the number of patient where ICA could be avoided was lower (Supplementary Table 2).</p></sec></sec></sec><sec id="Sec13"><title>Discussion</title><p id="Par31">The main goal of this study was the assessment of potential role of the Agatston score of the full coronary tree and proximal coronary segments as independent marker for coronary artery disease in need of interventional treatment in patients undergoing TAVI. Furthermore, for the first time this study provides data on proximal coronary artery segment Agatston score values in patients undergoing workup for TAVI.</p><p id="Par32">The main findings of our study are: (1) Overall, patients in need of percutaneous coronary intervention prior to TAVI showed significantly higher Agatston Score values for the full coronary tree and the proximal coronary artery segments compared to patients who did not need a coronary intervention. (2) Considering a threshold Agatston score value of 22 in the proximal RCA and 30 in the proximal LAD and CX as well as a sum score of the proximal segments of &gt;&#8201;117 allowed for a sensitivity&#8201;&#8805;&#8201;90% for prediction of a stenosis in need of interventional treatment. (3) Agatston values of the full coronary tree of &gt;&#8201;170 allowed for a sensitivity of 90% for prediction of need of a percutaneous coronary intervention.</p><sec id="Sec14"><title>Prediction of coronary stenosis in need of treatment</title><p id="Par33">In our study, we showed that full coronary tree as well as individual and combined proximal coronary artery Agatston score values allow for screening of a stenosis in need of treatment at high sensitivity levels of &#8805;&#8201;90%. Overall, the performance of the ROC analysis results can be classified as acceptable [<xref ref-type="bibr" rid="CR15">15</xref>]. The suggested cutoff values are 170 for the full coronary tree, 117 for the sum score of the proximal segments, 22 for the RCA (segment 1) and 30 for the LAD (segment 5 and 6) and CX (segment 11), respectively. The selected sensitivity is worthy of discussion and could be incorporated into a shared decision-making process with the patient concerned. A higher sensitivity would increase the certainty of not missing a stenosis but would lead to higher rates of invasive coronary angiography. In our opinion, a cut-off corresponding to a sensitivity of 90% is reasonable, as the evidence for stent implantation in patients, particularly without chest pain, is generally limited [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>].</p><p id="Par34">In 2022, Malebranche et al. have extensively addressed this topic in their work, reporting an AUC of 0.75 for Agatston scoring of the coronary tree for prediction of a stenosis&#8201;&gt;&#8201;50%, which is in good agreement to our results [<xref ref-type="bibr" rid="CR9">9</xref>]. However, this study used stenosis&#8201;&gt;&#8201;50% as benchmark, while we focused on stenoses that went on to receive interventional treatment, rendering our data more real-world applicable. While their study used Agatston values mainly as add-on to CTA to enhance diagnostic performance, our study further encompasses a segmental analysis of the coronary arteries with the Agatston Score which has not yet been done before. Further, their study suggests a cutoff of &gt;&#8201;100 for the full coronary tree, which is comparable to our suggested cutoff of 170 [<xref ref-type="bibr" rid="CR9">9</xref>]. Gohmann et al. 2024 also suggested an Agatston cutoff value of 110 for exclusion of CAD in their study of 460 patients prior to TAVI, which is in good agreement to our findings [<xref ref-type="bibr" rid="CR13">13</xref>].</p></sec><sec id="Sec15"><title>Role of the Agatston score on non-contrast CT vs. coronary CTA on TAVI evaluation CT</title><p id="Par35">In the past decade a multitude of research items has focused on assessment of coronary CTA in the framework of TAVI evaluation CT imaging [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR7">7</xref>&#8211;<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. In a meta-analysis by Gatti et al. in 2022, the authors have found coronary CTA in this framework to be an excellent diagnostic tool for exclusion of coronary artery disease [<xref ref-type="bibr" rid="CR18">18</xref>]. While the potential of coronary CTA in this specific framework is promising, relevant diagnostic limitations arise during image acquisition due to often extensive coronary calcifications and the aforementioned lack of heart-rate control and beta-blocker admission. This problem has to be considered in this framework and it is reflected in the published data, since in both recent and past research items non-evaluable coronary CT studies are mentioned in up to 20&#8211;84% of cases, representing a major diagnostic disadvantage [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. These issues are also discussed in a meta-analysis of 7458 patients in 2024 [<xref ref-type="bibr" rid="CR19">19</xref>]. The Agatston score, which is not affected by the acquisition limitations of CTA, can be a useful tool in this setting. Especially in the framework of artifact-impaired or non-diagnostic studies, our suggested cutoff values of 170 for the full coronary tree and 117 for the proximal segments allow for a more detailed assessment of coronary artery disease. Malebranche et al. 2022 have incorporated the Agatston score into CTA analysis in their study of 100 patients showing an increase in specificity of 18&#8211;39% depending on the applied cutoff value of 400 or 100 for the overall coronary artery Agatston score [<xref ref-type="bibr" rid="CR9">9</xref>]. The suggested cutoff values for the proximal coronary segments of our study of &gt;&#8201;22 for the RCA and &gt;&#8201;30 for the LAD and CX will allow for more comprehensive diagnostics in the per segment analysis and can counter the opposing limits in a CTA only approach.</p></sec><sec id="Sec16"><title>Considerations of non-contrast imaging prior to TAVI</title><p id="Par36">One of the main advantages of prediction of coronary artery disease with Agatston scoring is the avoidance of application of contrast media. Especially in the framework of Agatston scoring of the aortic valve, scoring of the coronary arteries can be done simultaneously. A possible application for this workflow is represented in patients with impaired renal function. Here, after non-contrast enhanced Agatston scoring further evaluation of the TAVI procedure can be performed with non-contrast MRI as described in multiple research items [<xref ref-type="bibr" rid="CR20">20</xref>&#8211;<xref ref-type="bibr" rid="CR23">23</xref>].</p></sec><sec id="Sec17"><title>Limitations</title><p id="Par37">This is a retrospective study with its associated limitations. This cohort only included patients who underwent TAVI evaluation with subsequent placement of a TAVI. With our patient collective being clearly defined, a large number of patients had to be excluded due to presence of metal artefacts and existing bypasses, which overall lowers the generalizability of our findings and has to be considered when interpreting our results. Furthermore, while our study shows promising results for coronary artery assessment with the Agatston score, both these findings and the potential benefit of segmental analysis combined with CTA should be further investigated in larger cohorts. It is important to mention that image acquisition was done with a tube voltage of 100 kVp, which may lead to an underestimation of Agatston score values. Lastly, Agatston scoring does not allow for the evaluation of non-calcified coronary artery plaques, which represents a limitation of the modality [<xref ref-type="bibr" rid="CR24">24</xref>].</p></sec></sec><sec id="Sec18"><title>Conclusion</title><p id="Par38">Agatston scoring on pre-TAVI CT of the full coronary tree and proximal coronary segments shows promise in predicting the need for percutaneous coronary intervention and in identifying patients who may safely forgo invasive coronary angiography. Although image artifacts limited assessability in a significant portion of cases, the consistent findings in evaluable scans support the potential clinical utility of this approach).</p></sec><sec id="Sec19" sec-type="supplementary-material"><title>Supplementary Information</title><p>Below is the link to the electronic supplementary material.<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xlink:href="10554_2025_3471_MOESM1_ESM.docx" position="float" orientation="portrait"><caption><p>Supplementary file1 (DOCX 154 KB)</p></caption></media></supplementary-material></p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>CT</term><def><p id="Par2">Computed tomography</p></def></def-item><def-item><term>CTA</term><def><p id="Par3">Computed tomography angiography</p></def></def-item><def-item><term>ICA</term><def><p id="Par4">Invasive coronary angiography</p></def></def-item><def-item><term>TAVI</term><def><p id="Par5">Transcatheter aortic valve implantation</p></def></def-item><def-item><term>ROC</term><def><p id="Par6">Receiver operating characteristics</p></def></def-item><def-item><term>AUC</term><def><p id="Par7">Area under the curve</p></def></def-item><def-item><term>LAD</term><def><p id="Par8">Left anterior descending coronary artery</p></def></def-item><def-item><term>CX</term><def><p id="Par9">Circumflex coronary artery</p></def></def-item><def-item><term>RCA</term><def><p id="Par10">Right coronary artery</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher&#8217;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Karim Mostafa and Jakob Christoph Voran contributed equally to this work.</p></fn><fn><p>Carmen Wolf and Hatim Seoudy are equal contributors to the lastauthorship.</p></fn></fn-group><ack><title>Acknowledgements</title><p>None.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>Conceptualization: H.S., K.M., J.V.; Data curation: K.M., J.V., M.M., M.N., A.P., M. Sal., C.W.; Formal analysis: J.V.; Investigation: K.M., J.V., M.M., A.P., M.Sal.,.L., D.F., C.W., H.S.; Methodology: K.M, J.V., C.W., H.S; Project administration: K.M., J.V., M. Saa., P.L., D.F., H.S. Software: K.M., J.V.; Resources: D.F., P.L. Supervision: P.L., D.F.; Visualization: J.V., K.M.; Writing &#8211; original draft: J.V., K.M.; Writing &#8211; review &amp; editing: K.M., J.V., M.M., A.P., M.Sal., M. Saa., M.N, P.L., D.F., C.W., H.S.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Open Access funding enabled and organized by Projekt DEAL. This research did not receive any funding.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>No datasets were generated or analysed during the current study.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par40">The study was approved by the ethics committee of the Christian-Albrechts-University in Kiel (Votum No. AZ D 506/22). All patients consented to participating in this retrospective study. The datasets used and analysed during the current study are available from the corresponding author on reasonable request.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par41">Written informed consent for publication was obtained from all participants in this study for publication of their personal and clinical details.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par42">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vahanian</surname><given-names>A</given-names></name><name name-style="western"><surname>Beyersdorf</surname><given-names>F</given-names></name><name name-style="western"><surname>Praz</surname><given-names>F</given-names></name><name name-style="western"><surname>Milojevic</surname><given-names>M</given-names></name><name name-style="western"><surname>Baldus</surname><given-names>S</given-names></name><name name-style="western"><surname>Bauersachs</surname><given-names>J</given-names></name><etal/></person-group><article-title>2021 ESC/EACTS guidelines for the management of valvular heart disease</article-title><source>Eur Heart J</source><year>2022</year><volume>43</volume><fpage>561</fpage><lpage>632</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehab395</pub-id><pub-id pub-id-type="pmid">34453165</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J et al (2022) 2021 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 43:561&#8211;632. 10.1093/eurheartj/ehab395<pub-id pub-id-type="pmid">34453165</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/eurheartj/ehab395</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Otto</surname><given-names>CM</given-names></name><name name-style="western"><surname>Nishimura</surname><given-names>RA</given-names></name><name name-style="western"><surname>Bonow</surname><given-names>RO</given-names></name><name name-style="western"><surname>Carabello</surname><given-names>BA</given-names></name><name name-style="western"><surname>Erwin</surname><given-names>JP</given-names></name><name name-style="western"><surname>Gentile</surname><given-names>F</given-names></name><etal/></person-group><article-title>2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: A report of the American college of cardiology/american heart association joint committee on clinical practice guidelines</article-title><source>J Am Coll Cardiol</source><year>2021</year><volume>77</volume><fpage>450</fpage><lpage>500</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2020.11.035</pub-id><pub-id pub-id-type="pmid">33342587</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F et al (2021) 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: A report of the American college of cardiology/american heart association joint committee on clinical practice guidelines. J Am Coll Cardiol 77:450&#8211;500. 10.1016/j.jacc.2020.11.035<pub-id pub-id-type="pmid">33342587</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jacc.2020.11.035</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chieffo</surname><given-names>A</given-names></name><name name-style="western"><surname>Giustino</surname><given-names>G</given-names></name><name name-style="western"><surname>Spagnolo</surname><given-names>P</given-names></name><name name-style="western"><surname>Panoulas</surname><given-names>VF</given-names></name><name name-style="western"><surname>Montorfano</surname><given-names>M</given-names></name><name name-style="western"><surname>Latib</surname><given-names>A</given-names></name><etal/></person-group><article-title>Routine screening of coronary artery disease with computed tomographic coronary angiography in place of invasive coronary angiography in patients undergoing transcatheter aortic valve replacement</article-title><source>Circ Cardiovasc Interv</source><year>2015</year><volume>8</volume><fpage>e002025</fpage><pub-id pub-id-type="doi">10.1161/CIRCINTERVENTIONS.114.002025</pub-id><pub-id pub-id-type="pmid">26160830</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Chieffo A, Giustino G, Spagnolo P, Panoulas VF, Montorfano M, Latib A et al (2015) Routine screening of coronary artery disease with computed tomographic coronary angiography in place of invasive coronary angiography in patients undergoing transcatheter aortic valve replacement. Circ Cardiovasc Interv 8:e002025. 10.1161/CIRCINTERVENTIONS.114.002025<pub-id pub-id-type="pmid">26160830</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCINTERVENTIONS.114.002025</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Habets</surname><given-names>J</given-names></name><name name-style="western"><surname>van den Brink</surname><given-names>RBA</given-names></name><name name-style="western"><surname>Uijlings</surname><given-names>R</given-names></name><name name-style="western"><surname>Spijkerboer</surname><given-names>AM</given-names></name><name name-style="western"><surname>Mali</surname><given-names>WPTM</given-names></name><name name-style="western"><surname>Chamuleau</surname><given-names>SAJ</given-names></name><name name-style="western"><surname>Budde</surname><given-names>RPJ</given-names></name></person-group><article-title>Coronary artery assessment by multidetector computed tomography in patients with prosthetic heart valves</article-title><source>Eur Radiol</source><year>2012</year><volume>22</volume><fpage>1278</fpage><lpage>1286</lpage><pub-id pub-id-type="doi">10.1007/s00330-011-2360-7</pub-id><pub-id pub-id-type="pmid">22193371</pub-id><pub-id pub-id-type="pmcid">PMC3348483</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Habets J, van den Brink RBA, Uijlings R, Spijkerboer AM, Mali WPTM, Chamuleau SAJ, Budde RPJ (2012) Coronary artery assessment by multidetector computed tomography in patients with prosthetic heart valves. Eur Radiol 22:1278&#8211;1286. 10.1007/s00330-011-2360-7<pub-id pub-id-type="pmid">22193371</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00330-011-2360-7</pub-id><pub-id pub-id-type="pmcid">PMC3348483</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harris</surname><given-names>BS</given-names></name><name name-style="western"><surname>de Cecco</surname><given-names>CN</given-names></name><name name-style="western"><surname>Schoepf</surname><given-names>UJ</given-names></name><name name-style="western"><surname>Steinberg</surname><given-names>DH</given-names></name><name name-style="western"><surname>Bayer</surname><given-names>RR</given-names></name><name name-style="western"><surname>Krazinski</surname><given-names>AW</given-names></name><etal/></person-group><article-title>Dual-source CT imaging to plan transcatheter aortic valve replacement: accuracy for diagnosis of obstructive coronary artery disease</article-title><source>Radiology</source><year>2015</year><volume>275</volume><fpage>80</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1148/radiol.14140763</pub-id><pub-id pub-id-type="pmid">25393848</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Harris BS, de Cecco CN, Schoepf UJ, Steinberg DH, Bayer RR, Krazinski AW et al (2015) Dual-source CT imaging to plan transcatheter aortic valve replacement: accuracy for diagnosis of obstructive coronary artery disease. Radiology 275:80&#8211;88. 10.1148/radiol.14140763<pub-id pub-id-type="pmid">25393848</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1148/radiol.14140763</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Matsumoto</surname><given-names>S</given-names></name><name name-style="western"><surname>Yamada</surname><given-names>Y</given-names></name><name name-style="western"><surname>Hashimoto</surname><given-names>M</given-names></name><name name-style="western"><surname>Okamura</surname><given-names>T</given-names></name><name name-style="western"><surname>Yamada</surname><given-names>M</given-names></name><name name-style="western"><surname>Yashima</surname><given-names>F</given-names></name><etal/></person-group><article-title>CT imaging before transcatheter aortic valve implantation (TAVI) using variable helical pitch scanning and its diagnostic performance for coronary artery disease</article-title><source>Eur Radiol</source><year>2017</year><volume>27</volume><fpage>1963</fpage><lpage>1970</lpage><pub-id pub-id-type="doi">10.1007/s00330-016-4547-4</pub-id><pub-id pub-id-type="pmid">27562479</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Matsumoto S, Yamada Y, Hashimoto M, Okamura T, Yamada M, Yashima F et al (2017) CT imaging before transcatheter aortic valve implantation (TAVI) using variable helical pitch scanning and its diagnostic performance for coronary artery disease. Eur Radiol 27:1963&#8211;1970. 10.1007/s00330-016-4547-4<pub-id pub-id-type="pmid">27562479</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00330-016-4547-4</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Andreini</surname><given-names>D</given-names></name><name name-style="western"><surname>Pontone</surname><given-names>G</given-names></name><name name-style="western"><surname>Mushtaq</surname><given-names>S</given-names></name><name name-style="western"><surname>Bartorelli</surname><given-names>AL</given-names></name><name name-style="western"><surname>Ballerini</surname><given-names>G</given-names></name><name name-style="western"><surname>Bertella</surname><given-names>E</given-names></name><etal/></person-group><article-title>Diagnostic accuracy of multidetector computed tomography coronary angiography in 325 consecutive patients referred for transcatheter aortic valve replacement</article-title><source>Am Heart J</source><year>2014</year><volume>168</volume><fpage>332</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1016/j.ahj.2014.04.022</pub-id><pub-id pub-id-type="pmid">25173545</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Andreini D, Pontone G, Mushtaq S, Bartorelli AL, Ballerini G, Bertella E et al (2014) Diagnostic accuracy of multidetector computed tomography coronary angiography in 325 consecutive patients referred for transcatheter aortic valve replacement. Am Heart J 168:332&#8211;339. 10.1016/j.ahj.2014.04.022<pub-id pub-id-type="pmid">25173545</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ahj.2014.04.022</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hamdan</surname><given-names>A</given-names></name><name name-style="western"><surname>Wellnhofer</surname><given-names>E</given-names></name><name name-style="western"><surname>Konen</surname><given-names>E</given-names></name><name name-style="western"><surname>Kelle</surname><given-names>S</given-names></name><name name-style="western"><surname>Goitein</surname><given-names>O</given-names></name><name name-style="western"><surname>Andrada</surname><given-names>B</given-names></name><etal/></person-group><article-title>Coronary CT angiography for the detection of coronary artery stenosis in patients referred for transcatheter aortic valve replacement</article-title><source>J Cardiovasc Comput Tomogr</source><year>2015</year><volume>9</volume><fpage>31</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1016/j.jcct.2014.11.008</pub-id><pub-id pub-id-type="pmid">25576406</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Hamdan A, Wellnhofer E, Konen E, Kelle S, Goitein O, Andrada B et al (2015) Coronary CT angiography for the detection of coronary artery stenosis in patients referred for transcatheter aortic valve replacement. J Cardiovasc Comput Tomogr 9:31&#8211;41. 10.1016/j.jcct.2014.11.008<pub-id pub-id-type="pmid">25576406</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jcct.2014.11.008</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Malebranche</surname><given-names>D</given-names></name><name name-style="western"><surname>Hoffner</surname><given-names>MKM</given-names></name><name name-style="western"><surname>Huber</surname><given-names>AT</given-names></name><name name-style="western"><surname>Cicovic</surname><given-names>A</given-names></name><name name-style="western"><surname>Spano</surname><given-names>G</given-names></name><name name-style="western"><surname>Bernhard</surname><given-names>B</given-names></name><etal/></person-group><article-title>Diagnostic performance of quantitative coronary artery disease assessment using computed tomography in patients with aortic stenosis undergoing transcatheter aortic-valve implantation</article-title><source>BMC Cardiovasc Disord</source><year>2022</year><volume>22</volume><fpage>178</fpage><pub-id pub-id-type="doi">10.1186/s12872-022-02623-8</pub-id><pub-id pub-id-type="pmid">35436856</pub-id><pub-id pub-id-type="pmcid">PMC9014581</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Malebranche D, Hoffner MKM, Huber AT, Cicovic A, Spano G, Bernhard B et al (2022) Diagnostic performance of quantitative coronary artery disease assessment using computed tomography in patients with aortic stenosis undergoing transcatheter aortic-valve implantation. BMC Cardiovasc Disord 22:178. 10.1186/s12872-022-02623-8<pub-id pub-id-type="pmid">35436856</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12872-022-02623-8</pub-id><pub-id pub-id-type="pmcid">PMC9014581</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rossi</surname><given-names>A</given-names></name><name name-style="western"><surname>de Cecco</surname><given-names>CN</given-names></name><name name-style="western"><surname>Kennon</surname><given-names>SRO</given-names></name><name name-style="western"><surname>Zou</surname><given-names>L</given-names></name><name name-style="western"><surname>Meinel</surname><given-names>FG</given-names></name><name name-style="western"><surname>Toscano</surname><given-names>W</given-names></name><etal/></person-group><article-title>CT angiography to evaluate coronary artery disease and revascularization requirement before trans-catheter aortic valve replacement</article-title><source>J Cardiovasc Comput Tomogr</source><year>2017</year><volume>11</volume><fpage>338</fpage><lpage>346</lpage><pub-id pub-id-type="doi">10.1016/j.jcct.2017.06.001</pub-id><pub-id pub-id-type="pmid">28662835</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Rossi A, de Cecco CN, Kennon SRO, Zou L, Meinel FG, Toscano W et al (2017) CT angiography to evaluate coronary artery disease and revascularization requirement before trans-catheter aortic valve replacement. J Cardiovasc Comput Tomogr 11:338&#8211;346. 10.1016/j.jcct.2017.06.001<pub-id pub-id-type="pmid">28662835</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jcct.2017.06.001</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abbara</surname><given-names>S</given-names></name><name name-style="western"><surname>Blanke</surname><given-names>P</given-names></name><name name-style="western"><surname>Maroules</surname><given-names>CD</given-names></name><name name-style="western"><surname>Cheezum</surname><given-names>M</given-names></name><name name-style="western"><surname>Choi</surname><given-names>AD</given-names></name><name name-style="western"><surname>Han</surname><given-names>BK</given-names></name><etal/></person-group><article-title>SCCT guidelines for the performance and acquisition of coronary computed tomographic angiography: A report of the society of cardiovascular computed tomography guidelines committee: endorsed by the North American society for cardiovascular imaging (NASCI)</article-title><source>J Cardiovasc Comput Tomogr</source><year>2016</year><volume>10</volume><fpage>435</fpage><lpage>449</lpage><pub-id pub-id-type="doi">10.1016/j.jcct.2016.10.002</pub-id><pub-id pub-id-type="pmid">27780758</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Abbara S, Blanke P, Maroules CD, Cheezum M, Choi AD, Han BK et al (2016) SCCT guidelines for the performance and acquisition of coronary computed tomographic angiography: A report of the society of cardiovascular computed tomography guidelines committee: endorsed by the North American society for cardiovascular imaging (NASCI). J Cardiovasc Comput Tomogr 10:435&#8211;449. 10.1016/j.jcct.2016.10.002<pub-id pub-id-type="pmid">27780758</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jcct.2016.10.002</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Opolski</surname><given-names>MP</given-names></name><name name-style="western"><surname>Kim</surname><given-names>W-K</given-names></name><name name-style="western"><surname>Liebetrau</surname><given-names>C</given-names></name><name name-style="western"><surname>Walther</surname><given-names>C</given-names></name><name name-style="western"><surname>Blumenstein</surname><given-names>J</given-names></name><name name-style="western"><surname>Gaede</surname><given-names>L</given-names></name><etal/></person-group><article-title>Diagnostic accuracy of computed tomography angiography for the detection of coronary artery disease in patients referred for transcatheter aortic valve implantation</article-title><source>Clin Res Cardiology: Official J German Cardiac Soc</source><year>2015</year><volume>104</volume><fpage>471</fpage><lpage>480</lpage><pub-id pub-id-type="doi">10.1007/s00392-014-0806-z</pub-id><pub-id pub-id-type="pmid">25559245</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Opolski MP, Kim W-K, Liebetrau C, Walther C, Blumenstein J, Gaede L et al (2015) Diagnostic accuracy of computed tomography angiography for the detection of coronary artery disease in patients referred for transcatheter aortic valve implantation. Clin Res Cardiology: Official J German Cardiac Soc 104:471&#8211;480. 10.1007/s00392-014-0806-z<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00392-014-0806-z</pub-id><pub-id pub-id-type="pmid">25559245</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="other">Gohmann RF, Lauten P, Seitz P, Krieghoff C, L&#252;cke C, Gottschling S et al (2020) Combined coronary CT-Angiography and TAVI-Planning: A Contrast-Neutral routine approach for Ruling-out significant coronary artery disease. J Clin Med 9. 10.3390/jcm9061623<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/jcm9061623</pub-id><pub-id pub-id-type="pmcid">PMC7356559</pub-id><pub-id pub-id-type="pmid">32471233</pub-id></mixed-citation></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Austen</surname><given-names>WG</given-names></name><name name-style="western"><surname>Edwards</surname><given-names>JE</given-names></name><name name-style="western"><surname>Frye</surname><given-names>RL</given-names></name><name name-style="western"><surname>Gensini</surname><given-names>GG</given-names></name><name name-style="western"><surname>Gott</surname><given-names>VL</given-names></name><name name-style="western"><surname>Griffith</surname><given-names>LS</given-names></name><etal/></person-group><article-title>A reporting system on patients evaluated for coronary artery disease. Report of the ad hoc committee for grading of coronary artery disease, Council on cardiovascular surgery</article-title><source>Am Heart Association Circulation</source><year>1975</year><volume>51</volume><fpage>5</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1161/01.cir.51.4.5</pub-id><pub-id pub-id-type="pmid">1116248</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS et al (1975) A reporting system on patients evaluated for coronary artery disease. Report of the ad hoc committee for grading of coronary artery disease, Council on cardiovascular surgery. Am Heart Association Circulation 51:5&#8211;40. 10.1161/01.cir.51.4.5<pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/01.cir.51.4.5</pub-id><pub-id pub-id-type="pmid">1116248</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mandrekar</surname><given-names>JN</given-names></name></person-group><article-title>Receiver operating characteristic curve in diagnostic test assessment. Journal of thoracic oncology: official publication of the international association for the study of</article-title><source>Lung Cancer</source><year>2010</year><volume>5</volume><fpage>1315</fpage><lpage>1316</lpage><pub-id pub-id-type="doi">10.1097/JTO.0b013e3181ec173d</pub-id><pub-id pub-id-type="pmid">20736804</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Mandrekar JN (2010) Receiver operating characteristic curve in diagnostic test assessment. Journal of thoracic oncology: official publication of the international association for the study of. Lung Cancer 5:1315&#8211;1316. 10.1097/JTO.0b013e3181ec173d<pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/JTO.0b013e3181ec173d</pub-id><pub-id pub-id-type="pmid">20736804</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tarantini</surname><given-names>G</given-names></name><name name-style="western"><surname>Tang</surname><given-names>G</given-names></name><name name-style="western"><surname>Nai Fovino</surname><given-names>L</given-names></name><name name-style="western"><surname>Blackman</surname><given-names>D</given-names></name><name name-style="western"><surname>van Mieghem</surname><given-names>NM</given-names></name><name name-style="western"><surname>Kim</surname><given-names>W-K</given-names></name><etal/></person-group><article-title>Management of coronary artery disease in patients undergoing transcatheter aortic valve implantation. A clinical consensus statement from the European association of percutaneous cardiovascular interventions in collaboration with the ESC working group on cardiovascular surgery. EuroIntervention: journal of EuroPCR in collaboration with the working group on interventional cardiology of the European society</article-title><source>Cardiol</source><year>2023</year><volume>19</volume><fpage>37</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.4244/EIJ-D-22-00958</pub-id><pub-id pub-id-type="pmcid">PMC10174192</pub-id><pub-id pub-id-type="pmid">36811935</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Tarantini G, Tang G, Nai Fovino L, Blackman D, van Mieghem NM, Kim W-K et al (2023) Management of coronary artery disease in patients undergoing transcatheter aortic valve implantation. A clinical consensus statement from the European association of percutaneous cardiovascular interventions in collaboration with the ESC working group on cardiovascular surgery. EuroIntervention: journal of EuroPCR in collaboration with the working group on interventional cardiology of the European society. Cardiol 19:37&#8211;52. 10.4244/EIJ-D-22-00958<pub-id pub-id-type="doi" assigning-authority="pmc">10.4244/EIJ-D-22-00958</pub-id><pub-id pub-id-type="pmcid">PMC10174192</pub-id><pub-id pub-id-type="pmid">36811935</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knuuti</surname><given-names>J</given-names></name><name name-style="western"><surname>Ballo</surname><given-names>H</given-names></name><name name-style="western"><surname>Juarez-Orozco</surname><given-names>LE</given-names></name><name name-style="western"><surname>Saraste</surname><given-names>A</given-names></name><name name-style="western"><surname>Kolh</surname><given-names>P</given-names></name><name name-style="western"><surname>Rutjes</surname><given-names>AWS</given-names></name><etal/></person-group><article-title>The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability</article-title><source>Eur Heart J</source><year>2018</year><volume>39</volume><fpage>3322</fpage><lpage>3330</lpage><pub-id pub-id-type="doi">10.1093/eurheartj/ehy267</pub-id><pub-id pub-id-type="pmid">29850808</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Knuuti J, Ballo H, Juarez-Orozco LE, Saraste A, Kolh P, Rutjes AWS et al (2018) The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability. Eur Heart J 39:3322&#8211;3330. 10.1093/eurheartj/ehy267<pub-id pub-id-type="pmid">29850808</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/eurheartj/ehy267</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gatti</surname><given-names>M</given-names></name><name name-style="western"><surname>Gallone</surname><given-names>G</given-names></name><name name-style="western"><surname>Poggi</surname><given-names>V</given-names></name><name name-style="western"><surname>Bruno</surname><given-names>F</given-names></name><name name-style="western"><surname>Serafini</surname><given-names>A</given-names></name><name name-style="western"><surname>Depaoli</surname><given-names>A</given-names></name><etal/></person-group><article-title>Diagnostic accuracy of coronary computed tomography angiography for the evaluation of obstructive coronary artery disease in patients referred for transcatheter aortic valve implantation: a systematic review and meta-analysis</article-title><source>Eur Radiol</source><year>2022</year><volume>32</volume><fpage>5189</fpage><lpage>5200</lpage><pub-id pub-id-type="doi">10.1007/s00330-022-08603-y</pub-id><pub-id pub-id-type="pmid">35192010</pub-id><pub-id pub-id-type="pmcid">PMC9279258</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Gatti M, Gallone G, Poggi V, Bruno F, Serafini A, Depaoli A et al (2022) Diagnostic accuracy of coronary computed tomography angiography for the evaluation of obstructive coronary artery disease in patients referred for transcatheter aortic valve implantation: a systematic review and meta-analysis. Eur Radiol 32:5189&#8211;5200. 10.1007/s00330-022-08603-y<pub-id pub-id-type="pmid">35192010</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00330-022-08603-y</pub-id><pub-id pub-id-type="pmcid">PMC9279258</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="other">Diller G-P, Gerwing M, Boroni Grazioli S, De-Torres-Alba F, Radke RM, Vormbrock J et al (2024) Utility of coronary computed tomography angiography in patients undergoing transcatheter aortic valve implantation: A Meta-Analysis and Meta-Regression based on published data from 7458 patients. J Clin Med 13. 10.3390/jcm13020631<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/jcm13020631</pub-id><pub-id pub-id-type="pmcid">PMC10816478</pub-id><pub-id pub-id-type="pmid">38276138</pub-id></mixed-citation></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pamminger</surname><given-names>M</given-names></name><name name-style="western"><surname>Klug</surname><given-names>G</given-names></name><name name-style="western"><surname>Kranewitter</surname><given-names>C</given-names></name><name name-style="western"><surname>Reindl</surname><given-names>M</given-names></name><name name-style="western"><surname>Reinstadler</surname><given-names>SJ</given-names></name><name name-style="western"><surname>Henninger</surname><given-names>B</given-names></name><etal/></person-group><article-title>Non-contrast MRI protocol for TAVI guidance: quiescent-interval single-shot angiography in comparison with contrast-enhanced CT</article-title><source>Eur Radiol</source><year>2020</year><volume>30</volume><fpage>4847</fpage><lpage>4856</lpage><pub-id pub-id-type="doi">10.1007/s00330-020-06832-7</pub-id><pub-id pub-id-type="pmid">32318849</pub-id><pub-id pub-id-type="pmcid">PMC7431439</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Pamminger M, Klug G, Kranewitter C, Reindl M, Reinstadler SJ, Henninger B et al (2020) Non-contrast MRI protocol for TAVI guidance: quiescent-interval single-shot angiography in comparison with contrast-enhanced CT. Eur Radiol 30:4847&#8211;4856. 10.1007/s00330-020-06832-7<pub-id pub-id-type="pmid">32318849</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00330-020-06832-7</pub-id><pub-id pub-id-type="pmcid">PMC7431439</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chaturvedi</surname><given-names>A</given-names></name><name name-style="western"><surname>Hobbs</surname><given-names>SK</given-names></name><name name-style="western"><surname>Ling</surname><given-names>FS</given-names></name><name name-style="western"><surname>Chaturvedi</surname><given-names>A</given-names></name><name name-style="western"><surname>Knight</surname><given-names>P</given-names></name></person-group><article-title>MRI evaluation prior to transcatheter aortic valve implantation (TAVI): when to acquire and how to interpret</article-title><source>Insights into Imaging</source><year>2016</year><volume>7</volume><fpage>245</fpage><lpage>254</lpage><pub-id pub-id-type="doi">10.1007/s13244-016-0470-0</pub-id><pub-id pub-id-type="pmid">26911969</pub-id><pub-id pub-id-type="pmcid">PMC4805621</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Chaturvedi A, Hobbs SK, Ling FS, Chaturvedi A, Knight P (2016) MRI evaluation prior to transcatheter aortic valve implantation (TAVI): when to acquire and how to interpret. Insights into Imaging 7:245&#8211;254. 10.1007/s13244-016-0470-0<pub-id pub-id-type="pmid">26911969</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s13244-016-0470-0</pub-id><pub-id pub-id-type="pmcid">PMC4805621</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bernhardt</surname><given-names>P</given-names></name><name name-style="western"><surname>Rodewald</surname><given-names>C</given-names></name><name name-style="western"><surname>Seeger</surname><given-names>J</given-names></name><name name-style="western"><surname>Gonska</surname><given-names>B</given-names></name><name name-style="western"><surname>Buckert</surname><given-names>D</given-names></name><name name-style="western"><surname>Radermacher</surname><given-names>M</given-names></name><etal/></person-group><article-title>Non-contrast-enhanced magnetic resonance angiography is equal to contrast-enhanced multislice computed tomography for correct aortic sizing before transcatheter aortic valve implantation</article-title><source>Clin Res Cardiology: Official J German Cardiac Soc</source><year>2016</year><volume>105</volume><fpage>273</fpage><lpage>278</lpage><pub-id pub-id-type="doi">10.1007/s00392-015-0920-6</pub-id><pub-id pub-id-type="pmid">26395021</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Bernhardt P, Rodewald C, Seeger J, Gonska B, Buckert D, Radermacher M et al (2016) Non-contrast-enhanced magnetic resonance angiography is equal to contrast-enhanced multislice computed tomography for correct aortic sizing before transcatheter aortic valve implantation. Clin Res Cardiology: Official J German Cardiac Soc 105:273&#8211;278. 10.1007/s00392-015-0920-6<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00392-015-0920-6</pub-id><pub-id pub-id-type="pmid">26395021</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="other">Pamminger M, Klug G, Reindl M, Reinstadler SJ, Tiller C, Kremser C et al (2019) 287Non-contrast MRI protocol for TAVI guidance: 3D whole heart and quiescent-interval single-shot angiography in comparison with contrast-enhanced CT. Eur Heart J - Cardiovasc Imaging 20. 10.1093/ehjci/jez114.005<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00330-020-06832-7</pub-id><pub-id pub-id-type="pmcid">PMC7431439</pub-id><pub-id pub-id-type="pmid">32318849</pub-id></mixed-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="other">Stefanini GG, Stortecky S, Wenaweser P, Windecker S Coronary artery disease in patients undergoing TAVI: why, what, when and how to treat. EuroIntervention: journal of EuroPCR in collaboration with the working group on interventional cardiology of the European society of cardiology 2014;10 suppl U:U69-75. 10.4244/EIJV10SUA10<pub-id pub-id-type="doi" assigning-authority="pmc">10.4244/EIJV10SUA10</pub-id><pub-id pub-id-type="pmid">25256334</pub-id></mixed-citation></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>